Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Growth Hormone Deficiency
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Ngenla
Indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone
Vaccines, Pneumococcal
Diabetes Mellitus
Renal Transplantation
Major Depressive Disorder
Complicated Intra-abdominal Infections